Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP533639.RAbJlQkGukQhijHXjL0mOgUDjgVNFOky8Whu7N_mHhK_U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP533639.RAbJlQkGukQhijHXjL0mOgUDjgVNFOky8Whu7N_mHhK_U130_assertion type Assertion NP533639.RAbJlQkGukQhijHXjL0mOgUDjgVNFOky8Whu7N_mHhK_U130_head.
- NP533639.RAbJlQkGukQhijHXjL0mOgUDjgVNFOky8Whu7N_mHhK_U130_assertion description "[To assess the expression of RET and protein products in relation to morphological types of FCDT, including follicular adenoma (FA), papillary carcinoma (PTC), follicular carcinoma (FTC) and anaplastic carcinoma (AnC), 58 non-neoplastic and neoplastic samples using pathological paraffin sections by immunohistochemistry (IHC), reverse transcriptase-polymerase chain reaction (RT-PCR) and laser capture microdissection (LCM) methods were analyzed.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP533639.RAbJlQkGukQhijHXjL0mOgUDjgVNFOky8Whu7N_mHhK_U130_provenance.
- NP533639.RAbJlQkGukQhijHXjL0mOgUDjgVNFOky8Whu7N_mHhK_U130_assertion evidence source_evidence_literature NP533639.RAbJlQkGukQhijHXjL0mOgUDjgVNFOky8Whu7N_mHhK_U130_provenance.
- NP533639.RAbJlQkGukQhijHXjL0mOgUDjgVNFOky8Whu7N_mHhK_U130_assertion SIO_000772 12608895 NP533639.RAbJlQkGukQhijHXjL0mOgUDjgVNFOky8Whu7N_mHhK_U130_provenance.
- NP533639.RAbJlQkGukQhijHXjL0mOgUDjgVNFOky8Whu7N_mHhK_U130_assertion wasDerivedFrom befree-20140225 NP533639.RAbJlQkGukQhijHXjL0mOgUDjgVNFOky8Whu7N_mHhK_U130_provenance.
- NP533639.RAbJlQkGukQhijHXjL0mOgUDjgVNFOky8Whu7N_mHhK_U130_assertion wasGeneratedBy ECO_0000203 NP533639.RAbJlQkGukQhijHXjL0mOgUDjgVNFOky8Whu7N_mHhK_U130_provenance.